Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway (Q38900042)

7 September 2017

title

Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway (English)

1 reference

7 September 2017

Yung-Hsin Yeh

1

1 reference

7 September 2017

Chi-Tai Kuo

2

1 reference

7 September 2017

Gwo-Jyh Chang

3

1 reference

7 September 2017

Ying-Hwa Chen

4

1 reference

7 September 2017

Ying-Ju Lai

5

1 reference

7 September 2017

Mei-Ling Cheng

6

1 reference

7 September 2017

Wei-Jan Chen

7

1 reference

7 September 2017

publication date

11 March 2015

1 reference

Journal of Molecular and Cellular Cardiology

7 September 2017

published in

1 reference

7 September 2017

volume

82

1 reference

7 September 2017

page(s)

84-92

1 reference

Atrial remodeling and atrial fibrillation: mechanisms and implications.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Structural remodeling in atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Role of Rac1 GTPase activation in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Pleiotropic effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Antioxidative effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

The association between heme oxygenase-1 gene promoter polymorphism and the outcomes of catheter ablation of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Microsatellite polymorphism in the heme oxygenase-1 gene promoter and the risk of atrial fibrillation in Taiwanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Rapid stimulation causes electrical remodeling in cultured atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Transcriptional remodeling of rapidly stimulated HL-1 atrial myocytes exhibits concordance with human atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Myeloid heme oxygenase-1 haploinsufficiency reduces high fat diet-induced insulin resistance by affecting adipose macrophage infiltration in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

The akt kinase: molecular determinants of oncogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

NADPH oxidase signaling and cardiac myocyte function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.03.004

10.1016/J.YJMCC.2015.03.004

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference